MCM
EXAS

Mitchell Capital Management’s Exact Sciences EXAS Stock Holding History

Mitchell Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-117,959
Closed -$2.12M – 32
2015
Q3 		$2.12M Buy
117,959
+317
+0.3% +$7.28K 0.74% 32
2015
Q2 		$3.5M Buy
117,642
+1,144
+1% +$28.7K 1.07% 32
2015
Q1 		$2.56M Buy
116,498
+2,853
+3% +$72.4K 0.79% 33
2014
Q4 		$3.12M Buy
113,645
+1,623
+1% +$39.5K 1.01% 33
2014
Q3 		$2.17M Buy
112,022
+1,553
+1% +$28.5K 0.72% 33
2014
Q2 		$1.88M Buy
110,469
+1,749
+2% +$24.1K 0.63% 35
2014
Q1 		$1.54M Buy
108,720
+1,910
+2% +$25.8K 0.53% 37
2013
Q4 		$1.25M Sell
106,810
-8,903
-8% -$102K 0.43% 35
2013
Q3 		$1.36M Buy
115,713
+1,806
+2% +$23.2K 0.45% 34
2013
Q2 		$1.58M Buy
+113,907
New +$1.24M 0.59% 34

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

Mitchell Capital Management's EXAS Position: Q4 2015 in Review

Mitchell Capital Management sold out of Exact Sciences (EXAS) in Q4 2015, closing a stake of 117,959 shares — an estimated $2.12M sold.

Mitchell Capital Management first reported a position in EXAS in Q2 2013 and held it in 10 quarters. The position peaked at $3.5M in Q2 2015. 183 funds tracked by Wall St. Rank hold EXAS as of Q4 2015.

  • Mitchell Capital Management reported no remaining Exact Sciences position as of Q4 2015 after selling out during the quarter.
  • Mitchell Capital Management sold 117,959 Exact Sciences shares in Q4 2015, an estimated $2.12M.
  • Mitchell Capital Management first reported a position in Exact Sciences in Q2 2013 and held it in 10 quarters.
  • Mitchell Capital Management's Exact Sciences position peaked at $3.5M in Q2 2015.
  • 183 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2015.

Based on Mitchell Capital Management's 13F filing for Q4 2015, filed 5 Feb 2016.